Form 4 for CRM Salesforce
Accepted 2026-03-24 00:00:00 ET · period of report 2026-03-22 · accession 0001108524-26-000074 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-24 | 2026-03-22 | CRM | Niles Sabastian | Pres, CLO | M - OptEx | $0.00 | +5,083 | 10.4K | +95% | $0 |
| DM | 2026-03-24 | 2026-03-22 | CRM | Niles Sabastian | Pres, CLO | F - Tax | $195.38 | -2,281 | 8,560 | -21% | -$445.7K |
| D | 2026-03-24 | 2026-03-22 | CRM | Niles Sabastian | Pres, CLO | A - Grant | $0.00 | +16.1K | 24.6K | +188% | $0 |
| DM | 2026-03-24 | 2026-03-22 | CRM | Niles Sabastian | Pres, CLO | A - Grant | $0.00 | +58.6K | 32.4K | New | $0 |
| DM | 2026-03-24 | 2026-03-22 | CRM | Niles Sabastian | Pres, CLO | M - OptEx | $0.00 | -5,083 | 8,124 | -38% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-22 | M | A | 1,015 | $0.00 | 6,773 | D | — | — | |
| 2 | Common | Common Stock | 2026-03-22 | F | D | 410 | $195.38 | 6,363 | D | — | — | |
| 3 | Common | Common Stock | 2026-03-22 | M | A | 4,068 | $0.00 | 10,431 | D | — | — | |
| 4 | Common | Common Stock | 2026-03-22 | F | D | 1,871 | $195.38 | 8,560 | D | — | — | |
| 5 | Common | Common Stock | 2026-03-22 | A | A | 16,084 | $0.00 | 24,644 | D | — | — | |
| 6 | Derivative | Restricted Stock Units | 2026-03-22 | A | A | 26,144 | $0.00 | 26,144 | D | $0.00 · 2027-03-22 to 2030-03-22 | 26,144 Common Stock | (F3) Restricted Stock Units convert to shares of common stock on a one-for-one basis. (F7) These restricted stock units vest as to 25% of the original grant on March 22, 2027 and vest as to 1/16 of the original grant quarterly thereafter. |
| 7 | Derivative | Performance Stock Option | 2026-03-22 | A | A | 32,418 | $0.00 | 32,418 | D | $280.62 · 2026-03-22 to 2032-03-22 | 32,418 Common Stock | |
| 8 | Derivative | Restricted Stock Units | 2026-03-22 | M | D | 4,068 | $0.00 | 12,207 | D | $0.00 · 2026-03-22 to 2029-03-22 | 4,068 Common Stock | (F3) Restricted Stock Units convert to shares of common stock on a one-for-one basis. (F5) These restricted stock snits vest as to 25% of the original grant on March 22, 2026 and vest as to 1/16 of the original grant quarterly thereafter. |
| 9 | Derivative | Restricted Stock Units | 2026-03-22 | M | D | 1,015 | $0.00 | 8,124 | D | $0.00 · 2025-03-22 to 2028-03-22 | 1,015 Common Stock | (F3) Restricted Stock Units convert to shares of common stock on a one-for-one basis. (F4) These restricted stock units vest as to 25% of the original grant on March 22, 2025 and vest as to 1/16 of the original grant quarterly thereafter. |